Evidence map›Paper›PMID 34729772›Full record

ArticleEpilepsia2022

Pilot study of focused ultrasound for drug-resistant epilepsy.

Cheng-Chia Lee, Chien-Chen Chou, Fu-Jung Hsiao, Yi-Hsiu Chen, Chun-Fu Lin, Ching-Jen Chen, Syu-Jyun Peng, Hao-Li Liu, Hsiang-Yu Yu

3 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Epilepsia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 59 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 4 pooled it
8.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06388707 phase1 / phase2recruitingnot on this mapstarted 2024, after this paper: background citation

A Prospective, Open-label, Single-arm, Multi-center, Pilot Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Unilateral or Bilateral Temporal Lobe Epilepsy

TypeinterventionalSponsorNaviFUS CorporationRan2024 to 2027Enrolled8ConditionsDrug Resistant Epilepsy, Epilepsy, Seizures, Focal, SeizureArmsNaviFUS System
NCT06492720 narecruitingnot on this mapstarted 2024, after this paper: background citation

A Pilot, Open-label, Two-arm, Parallel-group Randomized Trial Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy

TypeinterventionalSponsorNaviFUS CorporationRan2024 to 2027Enrolled16ConditionsDrug Resistant Epilepsy, Epilepsy, Epilepsy, Temporal Lobe, Seizures, FocalArmsFocused ultrasound (FUS) treatment
NCT07518927 naenrolling by invitationnot on this mapstarted 2026, after this paper: background citation

Mapping Low-Intensity Focused Ultrasound (LIFU)-Evoked Brain Network Responses Using Intracranial Electrophysiological Recordings

TypeinterventionalSponsorUniversity of PennsylvaniaRan2026 to 2031Enrolled30ConditionsLow Intensity Focussed Ultrasound, Electrodes, ImplantedArmsLow Intensity Focused Ultrasound
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 4 syntheses or guidelines pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Transcranial Focused Ultrasound Stimulation Targeting White Matter Inhibits Seizures in a Rat Model of Epilepsy.IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society · 2026
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Cheng-Chia LeeDepartment of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.
Chien-Chen ChouSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Fu-Jung HsiaoBrain Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Yi-Hsiu ChenDepartment of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.
Chun-Fu LinDepartment of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.
Ching-Jen ChenDepartment of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia, USA.
Syu-Jyun PengProfessional Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Hao-Li LiuDepartment of Electrical Engineering, National Taiwan University, Taipei, Taiwan.
Hsiang-Yu YuSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.ORCID 0000-0002-8183-1863
National Yang Ming Chiao Tung University · TWNational Taiwan University · TWTaipei Medical University · TWTaipei Veterans General Hospital · TWUniversity of Virginia Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe neuromodulatory effects of focused ultrasound (FUS) have been demonstrated in animal epilepsy models; however, the safety and efficacy of FUS in humans with epilepsy have not been well established. Patients with drug-resistant epilepsy (DRE) undergoing stereo-electroencephalography (SEEG) provide an opportunity to investigate the neuromodulatory effects of FUS in humans.

methodsPatients with DRE undergoing SEEG for localization of the seizure onset zone (SOZ) were prospectively enrolled. FUS was delivered to the SOZ using a neuronavigation-guided FUS system (ceiling spatial-peak temporal-average intensity level = 2.8 W/cm

resultsSix patients met the eligibility criteria and completed FUS treatment. A decrease in seizure frequency was observed in two patients within the 3-day follow-up; however, one patient presented an increase in the frequency of subclinical seizures. Posttreatment magnetic resonance imaging revealed neither lesion nor brain edema. Significant changes in spectral power of SEEG were noted at the targeted electrodes during FUS treatment. One patient reported subjective scalp heating during FUS, and one patient developed transient naming and memory impairment that resolved within 3 weeks after FUS. SIGNIFICANCE: FUS can be safely delivered to the SOZ of patients with DRE, resulting in significant changes in spectral power of SEEG. A larger sample cohort and pursuing optimal sonication parameters will be required to elucidate the neuromodulatory effects of FUS when used for seizure control.

Indexed as

Drug Resistant EpilepsyEpilepsyAnimalsElectroencephalographyHumansPilot ProjectsSeizuresdrug-resistant epilepsyfocused ultrasoundlow-intensityneuromodulationstereo-electroencephalography

Identifiers

PMID34729772
PMCPMC9297900
OpenAlexW3208829525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.